Hybrigenics, Dualsystems to Co-Market Yeast Two-Hybrid Screens for Membrane Proteins | GenomeWeb
NEW YORK (GenomeWeb News) – Hybrigenics said today that it has signed a co-marketing agreement with Dualsystems Biotech covering yeast two-hybrid screening services for full membrane proteins.
 
Under the terms of the agreement, both Dualsystems and Hybrigenics will commercialize Dualsystems’ DUALmembrane screens, which were designed for identifying protein interactions involving full membrane proteins.
 
Hybrigenics will perform the screens on its ISO 9001-certified yeast two-hybrid platform.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.